News ArchivesRead News
Cannabinoid Treatments May Offer Novel Therapy For Parkinson’s Disease
Thursday December 21, 2006
Frankfurt, Germany, December 21, 2006(Normal News) - Cannabis-based medicines could offer therapeutic relief for symptoms of Parkinson’s disease (PD) and may also moderate the course of the illness, according to a scientific review published this month in the journal Current Medicinal Chemistry.
"Cannabinoids are antioxidant, inhibit glutamate toxicity, and they also possess anti-inflammatory properties," authors state. "All together, we can conclude that cannabinoid-based medicines could be neuroprotective in the course of the disease, whereas [individual] compounds ... might modulate the behavioral effects of ... PD motor symptoms themselves."
Parkinson’s disease is a neurodegenerative disorder affecting the basal ganglia that results in a loss of motor coordination, organ failure, and death. The disease is characterized by a loss of dopaminergic neurons, typically resulting from brain inflammation, glutamate overproduction, and/or oxidative stress. The illness is estimated to affect approximately 2 percent of the population over age 65.
Survey data indicates that cannabis can provide subjective relief for symptoms of PD, including bradykinsia (extreme slowness of movement and reflexes), muscle rigidity, and tremor. However, a recent clinical trial assessing the short-term use of oral THC on symptoms of PD found the drug to have little immediate effect on patients’ movement.
For more information, please contact Paul Armentano, NORML Senior Policy Analyst, at (202) 483-5500. Full text of the study, "An overview of Parkinson’s disease and the cannabinoid system and possible benefits of cannabinoid-based treatments," appears in the December issue of Current Medicinal Chemistry
Recent NewsJun 13 - Brain Cell Transplants Are Being Tested Once Again For Parkinson's
Jun 12 - Smell Test May Sniff Out Oncoming Parkinson's and Alzheimer's
Jun 8 - Smartphones Track Motor Function in Parkinson's Disease
Jun 8 - GKC Enrolls First Patient in Personal KinetiGraph Trial as Part of NPF’s Parkinson’s Outcomes Project
Jun 8 - Low-fat dairy intake may raise Parkinson's risk
Jun 6 - Patient Voices: Parkinson's Disease
Jun 1 - World-First Trials Have Been Launched to Treat Parkinson's And Blindness With Embryonic Stem Cells
May 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis